Literature DB >> 1503900

Is there a relationship between regional microsphere distribution and hepatic arterial blood flow?

J H Anderson1, W J Angerson, N Willmott, D J Kerr, C S McArdle, T G Cooke.   

Abstract

The relationship between hepatic arterial albumin microsphere distribution and hepatic arterial blood flow and the effects of regional angiotensin II were studied in a rat liver metastases model. Hooded-Lister rats were inoculated subcapsularly with 2 x 10(6) HSN sarcoma cells. At 20 days, hepatic arterial blood flow was measured using the reference microsphere technique. Animals then randomly received 50 microliters hepatic arterial saline or albumin microspheres (40 microns, 20 mg ml-1). Hepatic arterial blood flow measurements were then repeated at 5 min. After 5 min, animals were killed and tissues were weighed and counted in a gamma well counter. There were no significant differences between the hepatic blood flow measurements recorded before and after the control hepatic arterial saline infusion. However, regional albumin microspheres produced a significant reduction in tumour and normal liver blood flow and an 80% reduction in mean T/N blood flow ratio. Regional albumin microspheres were delivered to tumour in greater proportions (mean T/N ratio 3.89, SE 0.49) than would be expected from baseline hepatic arterial blood flow (mean T/N ratio 1.28, SE 0.22. P = 0.006). There was no correlation between T/N for baseline blood flow and albumin microsphere distribution.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1503900      PMCID: PMC1977807          DOI: 10.1038/bjc.1992.258

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  11 in total

1.  Biodegradation rate of embolized protein microspheres in lung, liver and kidney of rats.

Authors:  N Willmott; Y Chen; J Goldberg; C Mcardle; A T Florence
Journal:  J Pharm Pharmacol       Date:  1989-07       Impact factor: 3.765

2.  Cytotoxic-loaded albumin microspheres: a novel approach to regional chemotherapy.

Authors:  C S McArdle; H Lewi; D Hansell; D J Kerr; J McKillop; N Willmott
Journal:  Br J Surg       Date:  1988-02       Impact factor: 6.939

3.  Reference sample method for cardiac output and regional blood flow determinations in the rat.

Authors:  A B Malik; J E Kaplan; T M Saba
Journal:  J Appl Physiol       Date:  1976-03       Impact factor: 3.531

4.  Changes in vascularity of liver tumours after hepatic arterial embolization with degradable starch microspheres.

Authors:  D Civalleri; G Scopinaro; N Balletto; F Claudiani; F De Cian; F DeCian; G Camerini; M DePaoli; U Bonalumi
Journal:  Br J Surg       Date:  1989-07       Impact factor: 6.939

5.  The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth.

Authors:  N B Ackerman
Journal:  Surgery       Date:  1974-04       Impact factor: 3.982

6.  Characteristics of microcirculation in experimental tumours.

Authors:  N V Krylova
Journal:  Bibl Anat       Date:  1969

7.  Hepatic malignancies: improved treatment with intraarterial Y-90.

Authors:  M J Herba; F F Illescas; M P Thirlwell; G J Boos; L Rosenthall; M Atri; P M Bret
Journal:  Radiology       Date:  1988-11       Impact factor: 11.105

8.  Adriamycin-loaded albumin microspheres: preparation, in vivo distribution and release in the rat.

Authors:  N Willmott; J Cummings; J F Stuart; A T Florence
Journal:  Biopharm Drug Dispos       Date:  1985 Jan-Mar       Impact factor: 1.627

9.  Angiotensin II as a potential method of targeting cytotoxic-loaded microspheres in patients with colorectal liver metastases.

Authors:  J A Goldberg; J A Thomson; M S Bradnam; J Fenner; R G Bessent; J H McKillop; D J Kerr; C S McArdle
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

10.  Influence of tumour growth on the evolution of cytotoxic lymphoid cells in rats bearing a spontaneously metastasizing syngeneic fibrosarcoma.

Authors:  G A Currie; J O Gage
Journal:  Br J Cancer       Date:  1973-08       Impact factor: 7.640

View more
  2 in total

Review 1.  Clinical pharmacokinetic advantages of new drug delivery methods for the treatment of liver tumours.

Authors:  J H Anderson; H W Warren; C S McArdle
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

2.  The Predictive Value of SPECT/CT imaging in colorectal liver metastases response after 90Y-radioembolization.

Authors:  Piotr Piasecki; Jerzy Narloch; Krzysztof Brzozowski; Piotr Zięcina; Andrzej Mazurek; Anna Budzyńska; Jan Korniluk; Mirosław Dziuk
Journal:  PLoS One       Date:  2018-07-10       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.